2. Gene
  3. CA2 - carbonic anhydrase 2 Gene

CA2 - carbonic anhydrase 2 Gene

  • 基因
  • 蛋白
  • 相关产品
  • 直系同源

中文名称：碳酸酐酶 2

种属: Macaca fascicularis

基因 ID: 101866067 | 基因类型: protein coding

关于 CA2

Primary_assembly 8: 84,728,135-84,746,456 forward strand.Macaca_fascicularis_6.0:CM021946.1

This gene has 1 transcript (splice variant), 285 orthologues and 14 paralogues.

CA2 基因产物(1)

mRNA Protein Name
XM_045398464.1 XP_045254399.1 carbonic anhydrase 2
蛋白主名 其他名称

carbonic anhydrase 2

相关产品

Approval
生物活性分子 (64)
目录号 产品名 作用方式
纯度 是否罕见病
HY-N0215 L-Phenylalanine Antagonist 99.98% 否
HY-10341 Fasudil Hydrochloride 99.97% 是
HY-B0246 Carbamazepine 99.95% 是
HY-A0057 Gabapentin Inhibitor 98.0% 是
HY-13764 Tetrandrine Inhibitor 99.90% 是
HY-B0561 Spironolactone 99.63% 是
HY-12542 Dantrolene Inhibitor 98.38% 是
HY-75161 (-)-Menthol Activator 99.79% 否
HY-B1221 Flufenamic acid 99.93% 否
HY-B1193 Terfenadine 99.98% 否
HY-14656 Diltiazem hydrochloride Antagonist 99.47% 是
HY-17404 Cilnidipine Inhibitor 99.72% 是
HY-B1077 Penfluridol 99.93% 否
HY-B0632 Diltiazem Inhibitor 99.70% 是
HY-N1370 Tanshinone IIA sulfonate sodium Inhibitor 99.77% 否
HY-15553A Mibefradil dihydrochloride Inhibitor 99.71% 是
HY-B1546A Benzamil hydrochloride Inhibitor 99.70% 否
HY-75839 Dronedarone Hydrochloride 99.99% 否
HY-A0057A Gabapentin hydrochloride Inhibitor 98.0% 是
HY-B0358A Flunarizine dihydrochloride 99.36% 是
HY-B0596 Taltirelin 99.91% 否
HY-12542A Dantrolene sodium hemiheptahydrate Inhibitor 99.79% 是
HY-A0082 Diphenidol hydrochloride Antagonist 99.95% 否
HY-14657 Dantrolene sodium Inhibitor 99.79% 是
HY-B1693 Levomepromazine 99.98% 否
HY-B1424 Benzthiazide Inhibitor 99.70% 否
HY-B1671 (+)-Kavain 99.98% 否
HY-16952A Bepridil hydrochloride hydrate Antagonist 99.86% 否
HY-B0473 Tetracaine hydrochloride Inhibitor 99.91% 否
HY-Y0258A Benzocaine hydrochloride 99.83% 否
HY-103370 Talniflumate Inhibitor 99.67% 是
HY-B0380A Trimebutine maleate 99.91% 是
HY-Z0478 (-)-Limonene Inhibitor 98.59% 否
HY-10341A Fasudil 99.91% 否
HY-B0380 Trimebutine 99.42% 是
HY-121186 Bevantolol hydrochloride Antagonist 98.98% 是
HY-U00212 Aranidipine Antagonist 99.12% 否
HY-16216 Gabapentin enacarbil Inhibitor 95.0% 是
HY-B0246R Carbamazepine (Standard) 99.97% 否
HY-108974 Drotaverine hydrochloride 99.65% 否
HY-112961 Patiromer Inhibitor 95.0% 否
HY-107319 Almitrine mesylate Inhibitor 99.81% 否
HY-109545 Isopropyl unoprostone Activator 95.10% 否
HY-109106A Upacicalcet sodium Agonist 99.91% 否
HY-A0135 Enflurane Inhibitor 98.0% 否
HY-A0236 Aprindine Inhibitor 98.43% 否
HY-B1457 Ouabain / 否
HY-10341C Fasudil dihydrochloride 99.98% 是
HY-B0596A Taltirelin acetate 99.38% 否
HY-P1769 Angiotensin II (5-8), human 99.68% 否
HY-15553 Mibefradil Inhibitor / 否
HY-109106 Upacicalcet Agonist / 否
HY-10341B Fasudil hydrochloride semihydrate / 否
HY-106916 Unoprostone Activator 99.0% 否
HY-14656R Diltiazem hydrochloride (Standard) Antagonist / 否
HY-75839R Dronedarone Hydrochloride (Standard) / 否
HY-A0270 Diphenidol Antagonist / 否
HY-B0401A Tolbutamide sodium Inducer / 否
HY-B0632A Diltiazem malate Inhibitor / 否
HY-B1546 Benzamil Inhibitor / 否
HY-B1558 Bifemelane / 否
HY-P1792 Angiotensin II (1-4), human Agonist / 否
HY-P1792A Angiotensin II (1-4), human TFA Agonist / 否
HY-B1693R Levomepromazine (Standard) / 否
Clinical Phase
生物活性分子 (41)
目录号 产品名 作用方式
纯度 Phase
HY-N6687 Calcimycin 99.12% Phase 4
HY-160187 AAA 98.40% Phase 4
HY-N6687A Calcimycin hemicalcium salt / Phase 4
HY-N6687B Calcimycin hemimagnesium / Phase 4
HY-50694 Senicapoc Inhibitor 99.91% Phase 3
HY-10805 Almorexant 99.96% Phase 3
HY-15724 Vercirnon Antagonist 98.01% Phase 3
HY-10805A Almorexant hydrochloride 99.98% Phase 3
HY-106449 Recoflavone 98.0% Phase 3
HY-Z7721 (Rac)-Beraprost sodium Inhibitor ≥99.0% Phase 3
HY-P0033A Argireline acetate Inhibitor / Phase 3
HY-N1584 Halofuginone 99.28% Phase 2
HY-10007 NPS-2143 Antagonist 99.94% Phase 2
HY-N1584A Halofuginone hydrobromide 99.99% Phase 2
HY-115864 Osavampator Activator 99.74% Phase 2
HY-10167A Tecalcet Hydrochloride Modulator 99.66% Phase 2
HY-15293B JTV-519 hemifumarate Inhibitor 99.74% Phase 2
HY-10066 Nelivaptan Antagonist 99.89% Phase 2
HY-147301 Resomelagon Agonist 98.79% Phase 2
HY-15724A Vercirnon sodium Antagonist 98.04% Phase 2
HY-B0340 Nefiracetam Activator 99.91% Phase 2
HY-19721 ABT-639 Inhibitor 99.32% Phase 2
HY-100779 Rimacalib Inhibitor 99.14% Phase 2
HY-100298 Caldaret Inhibitor 98.35% Phase 2
HY-100934 SC-9 Activator / Phase 2
HY-106904 Nexopamil Antagonist / Phase 2
HY-110312 JTV-519 fumarate / Phase 2
HY-113037B Farnesyl pyrophosphate Agonist / Phase 2
HY-169115 PD-0299685 / Phase 2
HY-106415 Terflavoxate Antagonist / Phase 2
HY-114826S Prostaglandin E2-1-glyceryl ester-d5 Activator / Phase 2
HY-108496 Sphingosine-1-phosphate Agonist 99.54% Phase 1
HY-100973A Adenosine 5′-diphosphoribose sodium 99.47% Phase 1
HY-129851 NTP42 Antagonist 98.58% Phase 1
HY-16935 Mavatrep Antagonist 99.67% Phase 1
HY-120588 BI 639667 Antagonist 99.47% Phase 1
HY-115681 (2R/S)-6-PNG Inhibitor 99.88% Phase 1
HY-133011 nAChR agonist 1 Agonist 98.35% Phase 1
HY-114793 AL-12180 Agonist / Phase 1
HY-118148 UK-66914 Inhibitor / Phase 1
HY-121701 SR33805 analog Antagonist / Phase 1
Pre-clinical Phase
生物活性分子 (649)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-13433 Thapsigargin 99.95% 否
HY-18723 Yoda 1 99.97% 否
HY-100545 BAPTA-AM Inhibitor 99.68% 否
HY-W009724 2-Aminoethyl diphenylborinate 99.86% 否
HY-101896 Fluo-4 AM ≥99.0% 否
HY-D0989 Rhod-2 AM ≥97.0% 否
HY-D0861 EGTA 98.0% 否
HY-P2149 Concanavalin A Inducer / 否
HY-N0219 Bicuculline Antagonist 99.97% 否
HY-100202 TPEN 99.91% 否
HY-19608 GSK1016790A 99.79% 否
HY-100168 BAPTA Inhibitor 98.10% 否
HY-10588 Bay K 8644 Agonist 99.96% 否
HY-126010 Dooku1 Antagonist 99.93% 否
HY-100831 YM-58483 Inhibitor 99.38% 否
HY-12323 ISX-9 Activator 99.19% 否
HY-118630 Vacuolin-1 Inhibitor 98.54% 否
HY-101455 CDN1163 Activator 99.90% 否
HY-138620 MCU-i4 Inhibitor 99.87% 否
HY-15084B Dizocilpine Antagonist 99.95% 否
HY-19805 STO-609 Inhibitor 98.20% 否
HY-119287 TSQ 99.50% 否
HY-100912 W-7 hydrochloride 99.96% 否
HY-101379A 8-Bromo-cGMP sodium Inhibitor 99.89% 否
HY-100001 SKF-96365 hydrochloride 99.71% 否
HY-15754 CGP37157 Inhibitor 99.87% 否
HY-113308A Taurolithocholic acid sodium salt Agonist 99.81% 否
HY-100560 Abscisic acid Inhibitor 99.73% 否
HY-D1024 Coelenterazine h 99.41% 否
HY-103312 Xestospongin C Inhibitor 99.0% 否
HY-N6732 K-252a Inhibitor 99.45% 否
HY-D0973 EGTA-AM 99.77% 否
HY-P0256 Apamin Inhibitor 99.96% 否
HY-120691A GSK205 Antagonist 99.47% 否
HY-P1410B D-GsMTx4 Inhibitor 99.59% 否
HY-101897 Fura-2 AM ≥99.0% 否
HY-D1498 Mag-Fluo-4 AM 96.0% 否
HY-P1410C D-GsMTx4 TFA Inhibitor 99.89% 否
HY-131614 TPC2-A1-N Inhibitor 99.86% 否
HY-103319 Calmidazolium chloride Antagonist 99.94% 否
HY-108599 DCP-LA 98.0% 否
HY-108465 Pyr3 Inhibitor 99.90% 否
HY-123071 Box5 Antagonist 99.24% 否
HY-N0215S12 L-Phenylalanine-d5 Antagonist 99.90% 否
HY-D0716 Fluo-3AM ≥99.0% 否
HY-101044 PPADS tetrasodium 95.0% 否
HY-123071A Box5 TFA Antagonist 99.24% 否
HY-N1502 Carboxyatractyloside tripotassium 99.97% 否
HY-P0033 Argireline Inhibitor 99.77% 否
HY-15515 SEA0400 Inhibitor 99.95% 否
HY-107543 8-pCPT-2′-O-Me-cAMP sodium Activator 99.81% 否
HY-116429 Maresin 1 Inhibitor 99.00% 否
HY-15415 KB-R7943 mesylate Inhibitor 99.16% 否
HY-116330A Hyperforin dicyclohexylammonium salt 99.48% 否
HY-15124 (S)-(-)-Bay-K-8644 Agonist 99.10% 否
HY-135897 Urolithin C ≥98.0% 否
HY-116522 AR420626 98.29% 否
HY-N6778 Paxilline Inhibitor 99.91% 否
HY-113037C Farnesyl pyrophosphate ammonium Agonist 95.0% 否
HY-133168 Englerin A Activator 99.50% 否
HY-101017 Palmitoylcarnitine chloride 98.0% 否
HY-107411 Bromoenol lactone Inhibitor 99.59% 否
HY-113328 Aminoadipic acid 99.86% 否
HY-N6789 KT5720 Inhibitor ≥99.0% 否
HY-N0043 Ginsenoside Rd Inhibitor 99.88% 否
HY-101906 DC260126 99.74% 否
HY-110105 NS8593 hydrochloride Inhibitor 99.76% 否
HY-W019981B Magnesium chloride hexahydrate, for molecular biology Activator 99.40% 否
HY-100168B BAPTA tetrapotassium Inhibitor 99.45% 否
HY-103474 Bicuculline methiodide Inhibitor 99.93% 否
HY-15416 NS309 Activator 99.09% 否
HY-P5712 Gramicidin S Inhibitor 99.89% 否
HY-B2149 Quadrol Activator 99.88% 否
HY-12949 ML204 Inhibitor 98.45% 否
HY-W018035 DL-Glyceric Acid (20% in water) ≥97.0% 否
HY-103660 18:0 LYSO-PE 99.0% 否
HY-19408 Pyr10 Inhibitor 99.95% 否
HY-157131 TRPV2-selective blocker 1 Inhibitor 99.84% 否
HY-Y1667 2,6-Dibromophenol Inhibitor 99.76% 否
HY-111208 CCT129957 Inhibitor 99.71% 否
HY-119401 CAY10444 Antagonist 98.0% 否
HY-P0189A ω-Conotoxin GVIA TFA Inhibitor 99.20% 否
HY-16697 CID 16020046 Antagonist 99.81% 否
HY-14229 TGR5 Receptor Agonist Agonist 99.71% 否
HY-126750 GNF362 Inhibitor 99.86% 否
HY-107658 SN 6 Inhibitor 99.79% 否
HY-W019981C Magnesium chloride hexahydrate, for cell culture Activator / 否
HY-Y0413 Biacetyl monoxime Inhibitor 98.0% 否
HY-120261 GB-88 Inhibitor 98.66% 否
HY-13103 NS 11021 Activator 99.51% 否
HY-N0515 Ophiopogonin D 99.80% 否
HY-N2522 Carboxyatractyloside dipotassium 99.57% 否
HY-P3278A Caloxin 2A1 TFA Inhibitor 99.92% 否
HY-N0601 Ginsenoside Rf Inhibitor 99.48% 否
HY-P1080A ω-Agatoxin IVA TFA Inhibitor 99.10% 否
HY-103309 ML218 Inhibitor 99.49% 否
HY-114252 Strophanthidin Inhibitor 98.53% 否
HY-149662 TMDJ-035 Inhibitor 99.92% 否
HY-P1345A TLQP-21 TFA Agonist 99.90% 否
HY-W194810 MCU-i11 98.42% 否
HY-162501 Yaddle1 Agonist 99.14% 否
HY-D1903 Fura Red AM 91.00% 否
HY-N0607 Ginsenoside Ro 99.81% 否
HY-16690 BTS Inhibitor 99.74% 否
HY-B0358 Flunarizine 99.93% 是
HY-103307 FPL64176 Agonist 99.86% 否
HY-100168A BAPTA tetrasodium Inhibitor 99.70% 否
HY-162426 UNC-CA2-103 Inhibitor 99.26% 否
HY-B0006C (R)-Carvedilol Inhibitor 98.78% 否
HY-124416 ML604086 Inhibitor 99.78% 否
HY-12496 NS-1619 98.06% 否
HY-18071 BI-9627 Inhibitor 99.71% 否
HY-16689 VU 0240551 Inhibitor 99.70% 否
HY-N0215S8 L-Phenylalanine-13C6 Antagonist 99.8% 否
HY-101360 1-EBIO Agonist 99.96% 否
HY-110153 NS19504 Activator 99.93% 否
HY-15671 GKA50 Activator 99.84% 否
HY-N0252 Catharanthine Inhibitor 99.65% 否
HY-10171 NPS-2143 hydrochloride Antagonist 99.98% 否
HY-120528A GB-110 hydrochloride Agonist 99.86% 否
HY-101015A OBAA 99.31% 否
HY-108593 BMS-191011 Activator 99.56% 否
HY-118010A (+)-Norfenfluramine hydrochloride Agonist 99.77% 否
HY-136409 N-Decanoyl-L-homoserine lactone 98.40% 否
HY-15292 S107 Ligand 99.77% 否
HY-P0190A Iberiotoxin TFA Inhibitor 99.05% 否
HY-P1845 PACAP-38 (31-38), human, mouse, rat Inducer 98.99% 否
HY-103320A Calhex 231 hydrochloride Inhibitor 99.81% 否
HY-N0215S1 L-Phenylalanine-d8 Antagonist 99.90% 否
HY-103306 Ryanodine Inhibitor 99.35% 否
HY-106844A (+)-EMD 57033 Agonist 99.72% 否
HY-N0126 Xanthone Inhibitor 99.97% 否
HY-N2344 Procyanidin A1 Inhibitor 99.19% 否
HY-N2500 Deoxypodophyllotoxin 99.87% 否
HY-N4104 Agaric acid 99.45% 否
HY-P3278 Caloxin 2A1 Inhibitor 99.86% 否
HY-157562 DS68591889 99.18% 否
HY-16992A W-54011 99.57% 否
HY-N0910 Notoginsenoside Ft1 98.0% 否
HY-101366 A-61603 Agonist 99.0% 否
HY-103316A Ned 19 Inhibitor 99.92% 否
HY-14350 AC-55541 Agonist 99.40% 否
HY-N0084 Betulinaldehyde Inhibitor 98.72% 否
HY-W131725 (+)-Norfenfluramine Agonist 99.92% 否
HY-120026 KB130015 98.45% 否
HY-16639 ML314 Agonist 99.52% 否
HY-130118 MRGPRX1 agonist 1 Agonist 99.95% 否
HY-P0190 Iberiotoxin Inhibitor 98.63% 否
HY-P1366 des-​Gln14-​Ghrelin 99.66% 否
HY-114400 TRPV4 agonist-1 free base Agonist 99.69% 否
HY-100712 DPO-1 Inhibitor 98.39% 否
HY-124873 SERCA2a activator 1 Activator 99.71% 否
HY-W001538 S-Propargylcysteine ≥97.0% 否
HY-101329 Anthracene-9-carboxylic acid Inhibitor 99.09% 否
HY-108607 PACOCF3 Inhibitor 98.0% 否
HY-160099 20-5,14-HEDE 98.34% 否
HY-34740 Ethylmalonic acid Inhibitor 98.0% 否
HY-D1024A Coelenterazine h hydrochloride 98.80% 否
HY-W110910 Eriochrome black T, Indicator / 否
HY-12927 SX-517 Antagonist 99.90% 否
HY-129440 N-(p-Coumaroyl) Serotonin Inhibitor 99.03% 否
HY-136460 Calcium ionophore I 99.6% 否
HY-137790 Bicuculline methochloride Antagonist 99.35% 否
HY-145542 Isovalerylcarnitine chloride Activator 99.48% 否
HY-N0215S10 L-Phenylalanine-13C9 Antagonist 98.09% 否
HY-101396 ICA-069673 Activator 99.20% 否
HY-N0215S3 L-Phenylalanine-d2 Antagonist 99.00% 否
HY-N6701 Dihydrocytochalasin B 99.0% 否
HY-P10655 Caloxin 1C2 Inhibitor 98.86% 否
HY-P1821A Myelin Basic Protein TFA 99.73% 否
HY-P2847 Urocortin II, mouse Agonist 98.63% 否
HY-P3965 16-38-Thymosin β4 (cattle) Activator 98.05% 否
HY-104058 Oregon-BAPTA Green 1AM 92.0% 否
HY-120597 SAK3 Activator 99.80% 否
HY-135891 AZD2423 Antagonist 99.91% 否
HY-N0215S5 L-Phenylalanine-15N Antagonist 98.10% 否
HY-N2081 Skimmianine Inhibitor 99.90% 否
HY-N7690 3,5,7,3′,4′-Pentamethoxyflavone Inhibitor 99.69% 否
HY-P1075 CALP3 Inhibitor 98.57% 否
HY-P1845A PACAP-38 (31-38), human, mouse, rat TFA Inducer 98.33% 否
HY-157453 CCR4 antagonist 4 Antagonist 99.72% 否
HY-12949A ML204 hydrochloride Inhibitor 99.74% 否
HY-12498 GV-58 Agonist 99.22% 否
HY-103442 CGP52411 Inhibitor 99.82% 否
HY-108464A Phenamil methanesulfonate Inhibitor 98.1% 否
HY-116291 4α-Phorbol 12,13-didecanoate 99.30% 否
HY-136909 SR33805 Antagonist 99.78% 否
HY-34740S Ethylmalonic acid-d3 Inhibitor 98.0% 否
HY-N2060 Evocarpine 99.88% 否
HY-N7063 Nerol 98.97% 否
HY-P1077A CALP1 TFA 99.86% 否
HY-W181102 NFAT Inhibitor-2 Inhibitor 98.42% 否
HY-103277A BIM 23042 TFA Antagonist 96.20% 否
HY-136190 TRPC6-PAM-C20 Agonist 99.78% 否
HY-D0202 Arsenazo III 95.0% 否
HY-E70200 Recombinant Kex2 protease / 否
HY-N8307 Syringaresinol 99.15% 否
HY-P0188A ω-Conotoxin MVIIC TFA Inhibitor 99.95% 否
HY-P1076A CALP2 TFA Antagonist 99.79% 否
HY-P4160 PDC31 Inhibitor 99.92% 否
HY-W041308 DCOIT Agonist 99.87% 否
HY-137175 TMBIM6 antagonist-1 Antagonist 98.92% 否
HY-100783 (-)-Bicuculline methobromide Antagonist 99.94% 否
HY-117073 ITH12575 Inhibitor 99.14% 否
HY-135746 OR-1896 99.04% 否
HY-136182A YM-244769 Inhibitor 99.22% 否
HY-136661 (-)-N6-Phenylisopropyl adenosine Agonist 99.45% 否
HY-158779 Sulfane sulfur probe 4 97.3% 否
HY-NP009 α-Lactalbumin 99% 否
HY-NP164 Concanavalin A-HRP / 否
HY-P3187 exo-β-1,4-Xylosidase, Cellulosimicrobium cellulans sp. 21 / 否
HY-41076 Ca2+ channel agonist 1 99.71% 否
HY-160023 Elisrasib Inhibitor 98.50% 否
HY-100928 YS 035 hydrochloride Antagonist 99.15% 否
HY-108592 UCL 2077 Inhibitor 98.91% 否
HY-108608 o-3M3FBS 99.88% 否
HY-128678 ORM-10103 Inhibitor 99.43% 否
HY-136182 YM-244769 dihydrochloride Inhibitor 98.57% 否
HY-162774A GRP75-IN-1 dihydrochloride Inducer 99.75% 否
HY-N0215S11 L-Phenylalanine-13C9,15N Antagonist 99.52% 否
HY-N0215S7 L-Phenylalanine-3-13C Antagonist 99.56% 否
HY-N1940 β-Anhydroicaritin Inhibitor 99.69% 否
HY-P0271A Syntide 2 TFA 99.22% 否
HY-P1247 Calcineurin autoinhibitory peptide Inhibitor 99.99% 否
HY-P1821 Myelin Basic Protein 98.98% 否
HY-W111226 Fmoc-His(3-Me)-OH Inhibitor ≥98.0% 否
HY-103308 TRAM-39 Inhibitor 99.66% 否
HY-146268 CaMKIIα-IN-1 Inhibitor 98.41% 否
HY-A0236A Aprindine hydrochloride Inhibitor 98.96% 否
HY-D0110A Fura-2 pentapotassium 97.0% 否
HY-P0256A Apamin TFA Inhibitor 98.35% 否
HY-P5189A His-D-beta-Nal-Ala-Trp-D-Phe-Lys-NH2 TFA 99.56% 否
HY-W010710 IPrAuCl Inhibitor 98.0% 否
HY-W012399 2,5-Di-tert-butylhydroquinone 99.90% 否
HY-N0215S2 L-Phenylalanine-13C Antagonist 99.66% 否
HY-N7491A Ent-(+)-Verticilide Inhibitor 99.91% 否
HY-105118A Zaldaride maleate Antagonist 99.7% 否
HY-103317 NAADP 95.8% 否
HY-103320B (1R,2R)-Calhex 231 hydrochloride Control 99.07% 否
HY-107855S DL-Mevalonolactone-d7 99.27% 否
HY-108496S Sphingosine-1-phosphate-d7 Agonist 99.00% 否
HY-11000A CaMKP inhibitor sodium Inhibitor 98.06% 否
HY-121584 Lycoperodine-1 Agonist 99.82% 否
HY-125703 Ferutinin 99.23% 否
HY-13338 Mabuterol Agonist 99.96% 否
HY-147301A Resomelagon acetate Agonist 99.75% 否
HY-161104 Kv2.1-IN-1 Inhibitor 98.64% 否
HY-18071A BI-9627 hydrochloride Inhibitor 98.01% 否
HY-B0493S1 Niflumic acid-13C6 Inhibitor 99.8% 否
HY-N1584C Halofuginone lactate 98.32% 是
HY-N2157 Pteryxin Inhibitor 99.96% 否
HY-N7117 1,4-Cineole Activator 95.0% 否
HY-P1250 RFRP-3(human) Agonist 99.43% 否
HY-P1479A Calmodulin-Dependent Protein Kinase II(290-309) acetate 98.45% 否
HY-P5914A Wasabi Receptor Toxin TFA Activator 99.49% 否
HY-W013857 Lavendustin C Inhibitor 98.32% 否
HY-N0742 Absinthin Agonist 98.0% 否
HY-14656S Diltiazem-d3 hydrochloride Antagonist 98.70% 否
HY-100402 CFMTI Antagonist 98.0% 否
HY-101428 NS-638 Inhibitor 99.84% 否
HY-103317A NAADP tetrasodium 95.8% 否
HY-103472 FPR-A14 Agonist 98.58% 否
HY-103544 [D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P 98.48% 否
HY-10388 TTA-Q6 Antagonist 99.97% 否
HY-10388A TTA-Q6(isomer) 99.91% 否
HY-111527 PPZ2 99.92% 否
HY-119282 AZD6538 Inhibitor / 否
HY-121604 (Rac)-MEM 1003 Inhibitor 99.64% 否
HY-129496 NP-313 Inhibitor 99.58% 否
HY-131012 GoSlo-SR-5-69 Activator 99.26% 否
HY-131948 3-Chlorodiphenylamine Activator 98.74% 否
HY-13699 NBI-42902 98.65% 否
HY-155480 PSB-22034 Agonist / 否
HY-155516 KV1.3-IN-1 Inhibitor 98.34% 否
HY-15705 GPR35 agonist 2 98.84% 否
HY-163796 GPR183-IN-2 Inhibitor 99.90% 否
HY-B1221S1 Flufenamic acid-13C6 99.5% 否
HY-D0121A INDO 1 pentapotassium 96.43% 否
HY-D1631 Calcium Green-5N AM / 否
HY-N10772 Albanin A Inhibitor 97.67% 否
HY-N6688 Verruculogen Inhibitor 97.52% 否
HY-N9404 6-Benzoylheteratisine Inhibitor 98.17% 否
HY-NP164B Concanavalin A-AF488 / 否
HY-P1387 β-Amyloid (1-40) (rat) Inducer 99.58% 否
HY-P1397A RVD-Hpα TFA Agonist 99.32% 否
HY-P3037A Imperatoxin A TFA Activator 98.65% 否
HY-P3617 Glucagon (22-29) Agonist 99.69% 否
HY-P3811A Autocamtide-3 acetate 99.62% 否
HY-126789A DM-Nitrophen tertasodium 90.0% 否
HY-150135B D-myo-Inositol 1,4,5-trisphosphate tripotassium Activator 98.00% 否
HY-145456 Gallium 8-Hydroxyquinolinate Inducer / 否
HY-101902 Quin-2AM / 否
HY-101015 (2E)-OBAA / 否
HY-101693A Senazodan hydrochloride Inhibitor 99.84% 否
HY-104056 Fura Red / 否
HY-107659 YM-244769 hydrochloride Inhibitor 99.02% 否
HY-107678 SEN12333 Agonist 98.45% 否
HY-110292 A-425619 99.96% 否
HY-111014 VK-II-36 Activator 99.63% 否
HY-112741 SB-209247 Antagonist 99.33% 否
HY-113037CS Farnesyl pyrophosphate-d2 triammonium Agonist 95.78% 否
HY-113970A Nebracetam hydrochloride Agonist 99.0% 否
HY-115745 Calmodulin antagonist-1 Antagonist 98.0% 否
HY-120514 JNc-440 98.04% 否
HY-120528 GB-110 Agonist / 否
HY-121825 U-44069 Control 98.0% 否
HY-12550 GW542573X Activator 98.79% 否
HY-126583 Nemadipine-A Inhibitor 98.0% 否
HY-131040 NLRP3-IN-NBC6 Inhibitor 99.40% 否
HY-136395 Cartap Inducer / 否
HY-145384 ROC-0929 Inhibitor 99.62% 否
HY-147005 piCRAC-1 Inhibitor 98.24% 否
HY-147384 CXL-1020 ≥99.0% 否
HY-15015 OT-R antagonist 1 Antagonist ≥98.0% 否
HY-15293A JTV-519 free base Inhibitor / 否
HY-15671A GKA50 quarterhydrate Activator ≥98.0% 否
HY-16489A Terodiline hydrochloride Antagonist 99.78% 否
HY-165607S MCB-22-174 99.78% 否
HY-169332 Piezo1 agonist 1-d2 / 否
HY-175416 Yoda2 / 否
HY-B1873 Methoxychlor Inducer 99.41% 否
HY-E70197A Calpain-1, Human Erythrocyte Modulator / 否
HY-N0126R Xanthone (Standard) Inhibitor 99.99% 否
HY-N0215S14 L-Phenylalanine-15N,d8 Antagonist 99.90% 否
HY-N0252A Catharanthine Tartrate Inhibitor 98.88% 否
HY-N2359 Chelerythrine / 否
HY-N4267 Yangambin Inhibitor 98.27% 否
HY-P0271 Syntide 2 / 否
HY-P1077 CALP1 98.44% 否
HY-P1079 ω-Agatoxin TK Inhibitor ≥99.0% 否
HY-P1424A Lei-Dab7 TFA Inhibitor 99.75% 否
HY-P1805 Calmodulin Binding Peptide 1 Inhibitor 98.68% 否
HY-P3037 Imperatoxin A Activator / 否
HY-P3965A 16-38-Thymosin β4 (cattle) (TFA) Activator 98.14% 否
HY-P5154A Tamapin TFA Antagonist 98.79% 否
HY-P5914 Wasabi Receptor Toxin Activator / 否
HY-P5988 N-myristoyl-RKRTLRRL Inhibitor 99.37% 否
HY-P6013A wt hMLN TFA Inhibitor 95.0% 否
HY-Q40876 BBT Modulator 99.71% 否
HY-101329S Anthracene-9-carboxylic acid-d9 98.94% 否
HY-101693 Senazodan Inhibitor / 否
HY-113040A (17R,18S)-Epoxyeicosatetraenoic acid Inhibitor 93.0% 否
HY-126789 DM-Nitrophen 98.40% 否
HY-12962 NMDA-IN-1 Antagonist 98.98% 否
HY-156663 Calcium Channel antagonist 2 Antagonist 98.0% 否
HY-N0215S L-Phenylalanine-d7 Antagonist 99.90% 否
HY-113037S1 Farnesyl pyrophosphate-d3 Agonist / 否
HY-113308AS Taurolithocholic acid-d4 sodium Agonist 99.4% 否
HY-114400A TRPV4 agonist-1 Agonist / 否
HY-102085 11-Deoxyglycyrrhetinic acid sodium Activator / 否
HY-103309A ML218 hydrochloride Inhibitor / 否
HY-125836 CCR4 antagonist 2 Antagonist / 否
HY-19805A STO-609 acetate Inhibitor / 否
HY-N1584B Halofuginone hydrochloride / 否
HY-B0632S Diltiazem-d6 Antagonist / 否
HY-P2471 Neurogranin (48-76), mouse Inhibitor / 否
HY-100783A (+)-Bicuculline methochloride Antagonist / 否
HY-100783B Bicuculline methobromide Antagonist / 否
HY-100981 MR-16728 hydrochloride / 否
HY-10167 Tecalcet Modulator / 否
HY-101685A Iganidipine di(hydrochloride) Antagonist / 否
HY-103277 BIM 23042 Antagonist / 否
HY-103309S ML218-d9 Inhibitor / 否
HY-103313 SR33805 oxalate Antagonist / 否
HY-103320 Calhex 231 Antagonist / 否
HY-103545 GIP (1-39) Agonist / 否
HY-105118 Zaldaride Inhibitor / 否
HY-106428 Icrocaptide Inhibitor / 否
HY-106818A Monatepil maleate / 否
HY-106837 Israpafant Antagonist / 否
HY-107855S1 DL-Mevalonolactone-d3 / 否
HY-109106B (Rac)-Upacicalcet 95.0% 否
HY-110140 (E)-KN-93 phosphate Inhibitor 99.85% 否
HY-111198 YM-355179 fumarate / 否
HY-111214 K-14585 / 否
HY-113308AS2 Taurolithocholic acid-d4-1 sodium Agonist / 否
HY-113920 Azumolene sodium Inhibitor / 否
HY-114691 R 59494 Inhibitor / 否
HY-114743 GS 283 Antagonist / 否
HY-114826 Prostaglandin E2-1-glyceryl ester Activator / 否
HY-115493 TIQ-15 Antagonist / 否
HY-115767 (±)-1,2-Diolein Activator / 否
HY-116153 HUHS2002 / 否
HY-116312 8-pCPT-2′-O-Me-cAMP Activator / 否
HY-116330 Hyperforin / 否
HY-116429A 7(S)-Maresin 1 / 否
HY-116429S Maresin 1-d5 Inhibitor / 否
HY-116500A AH-1058 Antagonist / 否
HY-117099 TMB-8 Antagonist / 否
HY-120355 AP14145 Inhibitor / 否
HY-120699 RO5488608 Modulator / 否
HY-120820 LY320954 Antagonist / 否
HY-120985 Araguspongin B Antagonist / 否
HY-121516 CM-TPMF / 否
HY-12153 JNJ-1930942 Modulator / 否
HY-12155 JNJ-26990990 Inhibitor / 否
HY-121690 Semotiadil Antagonist / 否
HY-121966 Riparin 98.00% 否
HY-124176 L-6355 / 否
HY-12542S Dantrolene-13C3 Inhibitor 99.0% 否
HY-125641A AL-34662 formate Agonist / 否
HY-12596 JNJ-26489112 / 否
HY-126821 Fluo-3 / 否
HY-126821A Fluo-3 pentaammonium / 否
HY-129088 HUP30 99.68% 否
HY-129547 Fluo-3 pentapotassium / 否
HY-12962A NMDA-IN-1 dihydrochloride Antagonist / 否
HY-130070 QO-40 Activator 98.77% 否
HY-130368 W-7 / 否
HY-131001 DPNB-ABT594 Agonist / 否
HY-131041 Ned-K / 否
HY-131942 sFTX-3.3 Antagonist / 否
HY-132190 Hexanolamino PAF C-16 Antagonist / 否
HY-133596 12,14-Dichlorodehydroabietic acid / 否
HY-135110 Rp-8-Br-cGMPS sodium / 否
HY-135433 MAPTAM / 否
HY-135478 LY393615 Inhibitor / 否
HY-136189 UK-59811 hydrochloride Inhibitor / 否
HY-136283 DMNPE-4 AM-caged-calcium Ligand / 否
HY-136894 Rhod-5N / 否
HY-13764A dl-Tetrandrine Inhibitor / 否
HY-138951 AY77 Agonist / 否
HY-138990 GK563 Inhibitor / 否
HY-139041 Palmitoylcholine chloride Inhibitor / 否
HY-142050 (R)-IDHP / 否
HY-142087 Beauverolide Ja Inhibitor / 否
HY-142117 Adenophostin A Modulator / 否
HY-145196 RTICBM-189 Modulator 99.73% 否
HY-145385 Coelenteramide / 否
HY-145542S Isovalerylcarnitine-d9 chloride / 否
HY-145900 S100A2-p53-IN-1 Inhibitor / 否
HY-146232 F 13714 Agonist / 否
HY-146461 Anticancer agent 58 / 否
HY-146462 Anticancer agent 59 / 否
HY-14656S1 Diltiazem-(acetoxy-d3) hydrochloride Antagonist / 否
HY-147186 5,5'-Difluoro BAPTA / 否
HY-147377 N-Salicyloyltryptamine 96.37% 否
HY-147383 NS-8 Activator / 否
HY-149483 CVN417 Antagonist / 否
HY-150039 CCG-271423 Inhibitor / 否
HY-15016 (E/Z)-OT-R antagonist 1 Antagonist / 否
HY-15018A SSR126768A free base Antagonist / 否
HY-151451 Cav 3.2 inhibitor 2 Inhibitor / 否
HY-151452 Cav 3.2 inhibitor 3 Inhibitor / 否
HY-151547 MRS4719 Antagonist / 否
HY-151547S MRS4719-d3 / 否
HY-15293 JTV-519 Inhibitor / 否
HY-156082 RyRs activator 3 Inhibitor / 否
HY-156104 CaMKIIα-PHOTAC Degrader / 否
HY-160508 NCX1-IN-1 Inhibitor / 否
HY-160998 YM-344031 Antagonist / 否
HY-161388 NSCLC-IN-1 Inducer / 否
HY-162280 PROTAC BTK Degrader-9 / 否
HY-162374 ANO61 Inhibitor / 否
HY-162375 AF299 / 否
HY-163795 GPR183-IN-1 Inhibitor / 否
HY-164682 AMD 3329 octahydrobromide Inhibitor / 否
HY-164684 Dichlorobenzamil Inhibitor / 否
HY-167091 (Rac)-Beraprost / 否
HY-169115A (Rac)-PD0299685 Ligand / 否
HY-169845 Calcium Channel antagonist 6 Antagonist / 否
HY-170424 D-myo-Inositol-1,3,4,5-tetrakisphosphate potassium / 否
HY-172772 Anti-PEDV agent 1 Inhibitor / 否
HY-173321 PAD4-IN-5 Inhibitor / 否
HY-173537 D-myo-Inositol-1,2,4,5-tetraphosphate tetrasodium salt / 否
HY-17404S Cilnidipine-d7 Inhibitor / 否
HY-174140 VU0514009 Antagonist / 否
HY-175593 M6766 / 否
HY-175675 P2Y1 antagonist 4 / 否
HY-176021 U-44069 serinol amide / 否
HY-176041 Troponin modulator 1 / 否
HY-176745 SW016789 Inducer 99.85% 否
HY-177091 AS2795440 Inhibitor / 否
HY-177296 GPR40 agonist 8 Agonist / 否
HY-19025 CV-159 Antagonist / 否
HY-19044 SKF 95601 / 否
HY-19409 AJG049 Antagonist / 否
HY-19857 Sulcardine sulfate / 否
HY-34740S1 Ethylmalonic acid-d5 Inhibitor 98.09% 否
HY-A0057AS2 Gabapentin-d4 hydrochloride Inhibitor / 否
HY-B0006CS (R)-Carvedilol-d4 Inhibitor / 否
HY-B0358AS Flunarizine-d8 dihydrochloride / 否
HY-B0380S1 Trimebutine-d5 fumarate / 否
HY-B0380S2 Trimebutine-d3 hydrochloride / 否
HY-B0596S Taltirelin-13C,d3 / 否
HY-B1221S Flufenamic acid-d4 / 否
HY-B1726 Phenacaine Inhibitor / 否
HY-B1837A β-Cyfluthrin Inhibitor 99.94% 否
HY-B1837AR β-Cyfluthrin (Standard) Inhibitor / 否
HY-D0121 INDO 1 / 否
HY-D0121B INDO 1 pentasodium / 否
HY-D0157 ZnAF-2 / 否
HY-D0861A EGTA tetrasodium / 否
HY-D1424 Coelenterazine hcp / 否
HY-D1501 Fura PE-3 potassium / 否
HY-D1608 BODIPY FL Thapsigargin Inhibitor / 否
HY-D1616 5-Bromo-5'-methyl BAPTA tetramethyl ester / 否
HY-D1631A Calcium green-5N hexapotassium / 否
HY-D1636 5-Nitro BAPTA / 否
HY-D1640 5',5-Difluoro BAPTA tetrapotassium / 否
HY-D1643 5,5'-Dinitro BAPTA AM / 否
HY-D1700 Mag-indo-1/AM / 否
HY-D1702 Mag-Fura-2 tetrapotassium / 否
HY-D1755 Fluo-3FF AM / 否
HY-E70197 Calpain-1 (pig) / 否
HY-E70234A Sortase A, S. aureus (non-Ca²⁺-dependent) / 否
HY-E70813 CAMKK2 Recombinant Human Active Protein Kinase / 否
HY-N0043R Ginsenoside Rd (Standard) Inhibitor / 否
HY-N0081A (-)-Praeruptorin A Inhibitor / 否
HY-N0215S13 L-Phenylalanine-d1 Antagonist / 否
HY-N0215S6 DL-Phenylalanine-d5 hydrochloride Antagonist / 否
HY-N0215S9 L-Phenylalanine-13C9,15N,d8 Antagonist / 否
HY-N0219R Bicuculline (Standard) Antagonist / 否
HY-N0252B Catharanthine Sulfate Inhibitor / 否
HY-N10512 Gangliotetraose / 否
HY-N10754 Aschantin Inhibitor / 否
HY-N11887 Linocinnamarin Inhibitor / 否
HY-N1228 Soyacerebroside I / 否
HY-N15735 Cimicifugic acid D Inhibitor / 否
HY-N15737 Fukinolic acid Inhibitor / 否
HY-N16129 Diplacone / 否
HY-N3729 (-)-Denudatin B Inhibitor ≥97.0% 否
HY-N4237 Saikogenin D 99.99% 否
HY-N5123 α-L-Rhamnose / 否
HY-N7063R Nerol (Standard) / 否
HY-N7594 Senecionine acetate / 否
HY-N7875 Celangulin / 否
HY-NP164A Concanavalin A-Cy5.5 / 否
HY-P0188 ω-Conotoxin MVIIC Inhibitor / 否
HY-P0189 ω-Conotoxin GVIA Inhibitor / 否
HY-P10316 CaMKI(299-320) Modulator / 否
HY-P10328 Vasoactive intestinal contractor Inhibitor / 否
HY-P10371 PKHB1 Activator / 否
HY-P1075A CALP3 TFA Inhibitor / 否
HY-P1076 CALP2 Antagonist / 否
HY-P10773 CTP-amiodarone Inhibitor / 否
HY-P1080 ω-Agatoxin IVA Inhibitor / 否
HY-P10811 Na2+ - Ca2+ Exchanger inhibitory peptide Inhibitor / 否
HY-P10972 GIP (22-51) human / 否
HY-P11019 IS4 Antagonist / 否
HY-P11082 APGW-amide / 否
HY-P11292 Caloxin 1b3 Inhibitor / 否
HY-P1247A Calcineurin autoinhibitory peptide TFA Inhibitor / 否
HY-P1250A RFRP-3(human) TFA Agonist / 否
HY-P1345 TLQP-21 Agonist / 否
HY-P1366A des-​Gln14-​Ghrelin TFA / 否
HY-P1437A Neuropeptide S(Mouse) TFA Agonist / 否
HY-P1640 (Trp63,Trp64)​-​C3a(63-77) Agonist / 否
HY-P2424 Cholecystokinin-J / 否
HY-P2722 Bovine brain Calcineurin / 否
HY-P3168 Martentoxin Inhibitor / 否
HY-P3187A exo-β-1,4-xylosidase, Clostridium stercorarium / 否
HY-P3187B exo-β-1,4-xylosidase, Bacteroides ovatus / 否
HY-P3316 OSK-1 Inhibitor / 否
HY-P3811 Autocamtide-3 / 否
HY-P3943 Calmodulin Dependent Protein Kinase Substrate Analog / 否
HY-P3944 Calmodulin Dependent Protein Kinase Substrate / 否
HY-P4368 Z-APF-CMK Inhibitor / 否
HY-P5154 Tamapin Antagonist / 否
HY-P5319 MCaE12A / 否
HY-P5422 Caloxin 3A1 Inhibitor / 否
HY-P5796 FS-2 Inhibitor / 否
HY-P5799 ω-Conotoxin MVIID Inhibitor / 否
HY-P5802 ω-Conotoxin FVIA Inhibitor / 否
HY-P5805 ω-Conotoxin CVIE Inhibitor / 否
HY-P5869 Kurtoxin / 否
HY-P5870 KTX-Sp2 Inhibitor / 否
HY-P6008 Myoregulin / 否
HY-P6008A Myoregulin TFA / 否
HY-P6013 wt hMLN Inhibitor / 否
HY-RS01768 CA2 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS01909 Car2 Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS01910 Car2 Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-U00026 Semotiadil recemate fumarate / 否
HY-W040028 Cartap hydrochloride Inducer / 否
HY-W170020 PTCA Ligand 99.72% 否
HY-W339833 1-Myristoyl-2-hydroxy-sn-glycero-3-phosphate sodium / 否
HY-W403046A D-myo-Inositol-4-phosphate monoammonium Activator / 否
HY-W641445 ELP-004 Inhibitor / 否
HY-W707161 4-Methyl-2-(1-piperidinyl)-quinoline-d10 / 否
HY-W710915 Aprindine hydrochloride-d10 Inhibitor / 否
HY-W711474 (-)-Menthol-d4 / 否
HY-W721517 Gabapentin-d10 / 否
HY-W748509 Pipernonaline / 否
HY-W783254 C18 LPA / 否
HY-Z8176 (Z)-Flunarizine Inhibitor / 否
HY-101616 ABT-639 hydrochloride Inhibitor / 否
HY-101669 TDN345 Antagonist / 否
HY-101685 Iganidipine Antagonist / 否
HY-101727 Nexopamil racemate / 否
HY-10341D Fasudil mesylate / 否
HY-108984 BBMP / 否
HY-110091 TRPV1 antagonist 9 Antagonist / 否
HY-113037AS Farnesyl pyrophosphate-d6 Agonist / 否
HY-113308AS1 Taurolithocholic Acid-d5 sodium salt Agonist / 否
HY-113723 MRS2298 Antagonist / 否
HY-115231 ci-IP3/PM / 否
HY-115767S (±)-1,2-Diolein-13C3 Activator / 否
HY-116072 Antiarrhythmic agent-2 Inhibitor / 否
HY-116723 CFMMC Antagonist / 否
HY-117055 Ro 18-3981 Inhibitor / 否
HY-117982 SKI2496 / 否
HY-121366 Kadethrin Inhibitor / 否
HY-121720 L 657925 Antagonist / 否
HY-121914 (2-Chlorophenyl)diphenylmethanol Inhibitor 99.56% 否
HY-130358 PDDHV Activator / 否
HY-131764 2'-O-MB-cGMP sodium Inhibitor / 否
HY-133614 Dihydroisopimaric acid Activator / 否
HY-134368 Ap3A Inhibitor / 否
HY-135110A Rp-8-Br-cGMPS / 否
HY-135478A LY393615 free base Inhibitor / 否
HY-136784A Rhod-2 sodium / 否
HY-137172 ETH 157 / 否
HY-141613A Dioleyl phosphatidylserine Activator / 否
HY-14656S2 Diltiazem-d6 hydrochloride Antagonist / 否
HY-147301B Resomelagon methanesulfonate Agonist / 否
HY-149779 RyR2 stabilizer-1 Modulator / 否
HY-152051S Mabuterol-d9 hydrochloride Agonist / 否
HY-154924 Thio-NADP / 否
HY-166363S Beraprost-d3 / 否
HY-167203 AJG049 free base Antagonist / 否
HY-168377 Fluo-4 potassium / 否
HY-168382 5R(6S)-EET Agonist / 否
HY-168382A 5S(6R)-EET Agonist / 否
HY-169206 PF-3166 Inhibitor / 否
HY-16935S Mavatrep-d6 Antagonist / 否
HY-169780 (S)-AMG-628 Antagonist / 否
HY-171469 SKP-451 Agonist / 否
HY-172321 Etheno-NAADP sodium / 否
HY-17404S1 Cilnidipine-d4 Inhibitor / 否
HY-174829 7,4'-Dimethoxy-3-hydroxyflavone / 否
HY-19062 SM-6586 / 否
HY-A0082S Diphenidol-d10 hydrochloride Antagonist / 否
HY-B0493S Niflumic Acid-d5 Inhibitor / 否
HY-B0632B (2R,3R)-Diltiazem hydrochloride Inhibitor / 否
HY-B0632S2 Diltiazem-d4 Inhibitor / 否
HY-B1193S Terfenadine-d3 / 否
HY-D0110B Fura-2 pentasodium / 否
HY-N13916 Alternaric acid / 否
HY-N7063S Nerol-d2 / 否
HY-N7063S1 Nerol-d6 / 否
HY-W150752 Triphenylethylene 99.86% 否
HY-W288025 ALXR-agonist-6 Agonist / 否
HY-W654243 Isovalerylcarnitine-d9-1 chloride Activator / 否
HY-W755295 Mabuterol hydrochloride Agonist / 否
HY-W931056 AMG-628 Inhibitor / 否
HY-132191 Pradimicin A Inhibitor / 否
HY-P1479 Calmodulin-Dependent Protein Kinase II (290-309) / 否
HY-U00354 CP-060 Antagonist / 否
抗体抑制剂 (1)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-P991646 ING-1 / 否

直系同源

种属 基因名 来源 基因 ID
Homo sapiens CA2 NCBI NCBI:760
Mus musculus CA2 NCBI
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z